6-Iodoquinoline

Catalog No.: 
ACIFTR972
CAS No.: 
13327-31-6
Molecular Formula: 
C9H6IN
Molecular Weight: 
255.06
6-Iodoquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$95.00In stockInquiry
100g98%$375.00In stockInquiry
500g98%$1434.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Iodoquinoline
IUPAC Name6-iodoquinoline
MDL No.MFCD08457906
Molecular FormulaC9H6IN
Molecular Weight255.06
SMILESIC2=CC=C1N=CC=CC1=C2
InChI KeyWKTASELJZCIVBR-UHFFFAOYSA-N
SynonymPS-7410 | AKOS005146263 | FT-0645784 | Quinoline, 6-iodo- | AM20070127 | CS-W003518 | A1-00823 | MFCD08457906 | J-518817 | A23334 | Z993990690 | SB71563 | BB 0262690 | SCHEMBL359732 | SY030914 | WKTASELJZCIVBR-UHFFFAOYSA-N | EN300-73850 | DTXSID20928030 |
CAS No.13327-31-6
PubChem CID20398553

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACIFTR972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWTZR230 route compound structure diagram
    ACWTZR230516-12-1In Stock
  2. Plus
  3. ACGTRE640 route compound structure diagram
    ACGTRE640376581-24-7In Stock
  4. Then
  5. ACIFTR972 route product structure diagram
    ACIFTR97213327-31-6In Stock
Inquiry

2. ACIFTR972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSKD057 route compound structure diagram
    ACZSKD057533-70-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIFTR972 route product structure diagram
    ACIFTR97213327-31-6In Stock
Inquiry

3. ACIFTR972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIFTR972 route product structure diagram
    ACIFTR97213327-31-6In Stock
Inquiry

Comments (0)